Startups
Nanospectra Biosciences is a medical device company pioneering a patient-centric use of nanomedicine for selective thermal ablation. AuroLase, the company's lead product for the ablation of prostate cancer tissue, is the first and only ultra-focal tissue ablation therapy designed to maximize treatment efficacy while minimizing side effects typically associated with surgery, radiation, and traditional focal therapies. Implementing a multi-prong growth strategy, Nanospectra is focusing on clinical advancements, exclusive partnering agreements and ongoing research and development. Nanospectra’s technology development has been funded to date by a series of grants, private equity investments and corporate partnerships.
Overview
Location
United States, Texas, Houston
Employees
11-50
Founded date
2001
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 29, 2019 | TMCx company raises $16 million, Exxon scales work with Houston drone startup, and more innovation news | With a busy September just days away, the Houston innovation world has seen an uptick in news. Just in case you missed some, here are some short stories from Houston startups — funding, product launches, clinical trials, oh my. TMC invests ... |
| Nov 13, 2012 | Laser heated nanoparticles that destroy tumors could be innovative approach to lung cancer | Dr. Mark Lund, CTCA director of interventional pulmonology, bronchoscopy and the Advanced Center for Lung and Thoracic Oncology, said he would be doing the procedure on 10 patients in its Philadelphia center. They will be monitored for a fe... |
| Laser heated nanoparticles that destroy tumors could be innovative approach to lung cancer | A therapeutic diagnostics company and Cancer Treatment Centers of America are embarking on a pilot study of an innovative approach to get rid of tumors using lasers and nanoparticles. It is the first time the technology is being used in the... | |
| Nanospectra Biosciences | “Nanospectra | Leveraging Nanoshells in the First True Focal Therapy” |
Reviews 0
FAQ about Nanospectra Biosciences, Inc.
When was Nanospectra Biosciences, Inc. founded?
Nanospectra Biosciences, Inc. was founded in 2001.
What has the press written about Nanospectra Biosciences, Inc.?
Parsers VC has collected 5 articles mentioning Nanospectra Biosciences, Inc., among them “TMCx company raises $16 million, Exxon scales work with Houston drone startup, and more innovation news” (Aug 29, 2019) and “Laser heated nanoparticles that destroy tumors could be innovative approach to lung cancer” (Nov 13, 2012).
Is Nanospectra Biosciences, Inc. still active?
Yes, Nanospectra Biosciences, Inc. is active; its latest activity on Parsers VC dates from Sep 8, 2020.